The Effectiveness of Dadimavaleha as a Supplement to Iron- Folic Acid for Managing Garbhini Pandu (Anemia in Pregnancy)

A Randomized Comparative Clinical Study on the Efficacy of Dadimavaleha as an Adjuvant to Iron-Folic Acid (IFA) versus Iron-Folic Acid (IFA) in the Management of Garbhini Pandu (Anemia in Pregnancy) - NIL

Status

Active, not recruiting

Phases

Phase 2Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2026/02/104318

Enrollment

Registered

2026-02-19

Start date

Unknown

Completion date

Unknown

Last updated

2026-03-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: D50-D53- Nutritional anemias

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: 1.Participant in 2nd trimester of Pregnancy. 2.Hemoglobin % in between 8 to 10 gm%. 3.Participant within age group of 20 to 40 years. 4.The clinical symptoms Pallor general weakness Anorexia include.

Exclusion criteria

Exclusion criteria: 1.The participant suffering from following condition were excluded from study Liver cirrhosis Bleeding hemorrhoids Tuberculosis Blood cancer 2.Anemia due to Thalassemia Sickle cell Anemia Pernicious Anemia. 3.Participant with heart disease diabetes mellitus and pregnancy induced hypertension. 4.From assessment criteria grade no. 3 of Daurbalya Weakness was excluded. 5.From assessment criteria grade no. 3 of Panduta Pallor was excluded. 6.From assessment criteria grade no 4 of Aruchi Anorexia was excluded.

Design outcomes

Primary

Measure	Time frame
The primary outcome of the study is to compare the effect of Efficacy of Dadimavaleha as an Adjuvant to Iron-Folic Acid (IFA)versus Iron-Folic Acid (IFA) on Hemoglobin levelTimepoint: Hemoglobin levels and clinical symptoms will be assessed at Day 0,1 month,2 month and 3 month.	—

Secondary

Measure	Time frame
1.To compare the clinical symptoms (Pallor, Weakness, & Anorexia) in both groups. 2.To re-evaluate the efficacy of Dadimavleha. Timepoint: Hemoglobin levels & clinical symptoms will be assessed at Day 0,1 month,2 month & 3 month.	—

Countries

India

Contacts

Public ContactSamruddhi Ravilal Lade

Dr.Rajendra Gode Ayurved College Hospital and Research Centre

pudgal9@gmail.com9284295220

Outcome results